Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

Abstract Background Antibody-drug conjugates (ADCs) targeting the RON receptor, a tumorigenic factor contributing to cancer malignancy, has been considered as a novel strategy for cancer therapy. Here we describe a humanized antibody recognizing the RON plexin-semaphorin-integrin (PSI) domain with i...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Xiang-Min Tong, Liang Feng, Sreedhar Reddy Suthe, Tian-Hao Weng, Chen-Yu Hu, Yi-Zhi Liu, Zhi-Gang Wu, Ming-Hai Wang, Hang-Ping Yao
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2019-09-01
Saila:	Journal for ImmunoTherapy of Cancer
Gaiak:	RON receptor tyrosine kinase PSI domain Monoclonal antibody Humanization Antibody-drug conjugates Receptor internalization
Sarrera elektronikoa:	http://link.springer.com/article/10.1186/s40425-019-0732-8
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!